Cogent Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $232.1M
Liabilities Breakdown FY2021
Total Liabilities: $17.9M
Asset Breakdown
Total Assets: $232.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $219.7M | 94.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.7M | 0.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $10.7M | 4.6% |
Liabilities Breakdown
Total Liabilities: $17.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.5M | 19.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $14.4M | 80.6% |